Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
28.59
-0.33 (-1.12%)
Streaming Delayed Price
Updated: 12:31 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
32
33
Next >
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
January 03, 2023
From
Pfizer Inc.
Via
Business Wire
The Year of the Tripledemic
January 03, 2023
COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically disabled from long-COVID, 4 million of which...
Via
TheNewswire.com
Topics
Death
Exposures
COVID-19
Death
Product Safety
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
December 29, 2022
From
Pfizer Inc.
Via
Business Wire
Big Health Care Stocks to Watch in the New Year
December 29, 2022
Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now.
Via
MarketBeat
U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
December 28, 2022
From
Pfizer Inc.
Via
Business Wire
Why Did Immutep Ltd Stock Soar Recently?
December 28, 2022
Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate.
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Product Safety
Securities Market
Vaccines & Vaccination Market May Set Epic Growth Story : Pfizer, Merck, Johnson & Johnson
December 22, 2022
Stay up-to-date with Vaccines & Vaccination Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences
December 28, 2022
Ghosh Brings Three Decades of Life Sciences Experience to DeepThink HealthSAN RAMON, Calif. - Dec. 28, 2022 - PRLog -- DeepThink Health, Inc., an AI-powered leader in the transformation of health data...
Via
PRLog
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
December 21, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts
December 20, 2022
From
Pfizer Inc.
Via
Business Wire
Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
December 19, 2022
Eli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentum
Via
MarketBeat
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore
December 19, 2022
From
LianBio; Pfizer Inc.
Via
GlobeNewswire
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing...
Via
TheNewswire.com
Topics
Death
Exposures
Death
NYSE:PFE Investor Notice: Investigation over Breaches of Fiduciary Duties at Pfizer Inc.
December 13, 2022
San Diego, CA -- (SBWIRE) -- 12/13/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Pfizer Inc.
Via
SBWire
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial
December 10, 2022
From
Pfizer Inc.
Via
Business Wire
MarketBeat: Week in Review 12/05 – 12/09
December 10, 2022
The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week.
Via
MarketBeat
Topics
Economy
Electric Vehicles
Supply Chain
Exposures
Electric Vehicles
Interest Rates
Supply Chain
Pfizer Declares First-Quarter 2023 Dividend
December 09, 2022
From
Pfizer Inc.
Via
Business Wire
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
December 09, 2022
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.
Via
MarketBeat
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
December 08, 2022
From
Pfizer Inc.
Via
Business Wire
AAPS Executive Director in Journal of American Physicians and Surgeons Discusses Whether Blood Clots After COVID Vaccines Are an Ignored Crisis
December 07, 2022
Despite official reassurances that adverse effects of COVID vaccines are rare or mild, some patients still have concerns, and social media is filled with reports. In the winter issue of the Journal of...
Via
Newswire.com
Exposures
COVID-19
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults
December 07, 2022
From
Pfizer Inc.
Via
Business Wire
Nanomedicine Market Size & Share Report 2022 : Reach at US$ 238.4 Bn and Grow at Healthy CAGR 10.1% During Forecast Period 2022-2028
December 06, 2022
"Emerging innovative technologies for drug delivery, the benefits of nanomedicine in various healthcare applications, and the increase in the demand for safe and inexpensive treatments drive the growth...
Via
SBWire
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
December 06, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
December 01, 2022
From
Pfizer Inc.
Via
Business Wire
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
December 01, 2022
From
Roivant Sciences
Via
GlobeNewswire
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
November 30, 2022
Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Longwood Healthcare Leaders to Bring Together Several Hundred Top Biotech and Pharmaceutical Leaders on Jan. 5-6, 2023
November 30, 2022
Longwood Fund, an early-stage life science venture firm, will convene several hundred top biotech and pharmaceutical leaders at its Pre-JPM Longwood Healthcare Leaders meeting, hosted virtually via...
Via
Newswire.com
Exposures
Product Safety
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 28, 2022
From
Pfizer Inc.
Via
Business Wire
Nutraceutical Supplements Market to Witness Huge Growth : Glanbia, Pfizer, Bayer, DowDuPont
November 25, 2022
Understand focused approach and business strategies that competitors are keeping to reach target audience, Get one step closer to leaders and high growth emerging players of Nutraceutical Supplements...
Via
SBWire
Graphic design as a service Company Doozoo secures strategic investment partner, launches fresh branding and expands resource within USA to meet growing global demand.
November 22, 2022
Via
Get News
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.